{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:02:21Z","timestamp":1789970541210,"version":"4.0.1"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although associations between overt vascular injury and Alzheimer\u2019s disease (AD) have been reported, the role of subclinical vascular injury in dementia pathogenesis remains unclear. Cerebrospinal fluid (CSF) biomarkers related to endothelial dysfunction may capture subclinical vascular impairment and provide insights into early AD pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We examined associations of ten CSF biomarkers (PDGFR\u03b2, Osteopontin, VCAM-1, E-selectin, MMP-2, MMP-10, MMP-3, MMP-12, MMP-9\/TIMP-1 ratio and Periostin) with AD core biomarkers, brain volume, cognitive function, and risk of incident AD among 444 participants. Multivariable linear regression, linear mixed-effects models, Cox proportional hazards models, mediation analyses, and 3-year time-dependent ROC analyses were applied. All models were adjusted for demographic factors,\n                      <jats:italic>APOE<\/jats:italic>\n                      \u03b54 status, and vascular risk factors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seven of ten biomarkers were significantly associated with CSF tau biomarkers, whereas two biomarkers were associated with CSF A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      . Mediation analyses suggested that CSF tau biomarkers statistically accounted for a greater proportion of the associations between MMP-10 and cognition than did A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      . Among the biomarkers examined, MMP-10 showed the most consistent associations across AD-related outcomes, including lower CSF A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      , higher CSF tau biomarkers, poorer cognitive performance, greater longitudinal brain atrophy, and increased risk of incident AD dementia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Cerebrospinal fluid biomarkers related to endothelial dysfunction and vascular injury were more consistently associated with CSF tau biomarkers than with CSF A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      in non-demented individuals. MMP-10 showed the most consistent pathological, cognitive, neuroimaging, and prognostic associations and provided incremental predictive information for incident AD dementia. These findings support further investigation of endothelial dysfunction-related and vascular remodeling pathways as potential correlates of AD progression.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2026.1744647","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:36:05Z","timestamp":1789968965000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations between cerebrospinal fluid biomarkers related to endothelial dysfunction and Alzheimer\u2019s disease"],"prefix":"10.3389","volume":"18","author":[{"given":"Yang-Ke","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Jie","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Southeast University, Nanjing","place":["Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Ying","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Jie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital)","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Hao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Neurology, Jiangxi Academy of Clinical Medical Sciences, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang","place":["Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University","place":["Qingdao, China"]},{"name":"Department of Neurology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital)","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University","place":["Qingdao, China"]},{"name":"Department of Neurology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital)","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University","place":["Qingdao, China"]},{"name":"Department of Neurology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital)","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"116989","DOI":"10.1016\/j.jns.2020.116989","article-title":"Influence of plasma matrix metalloproteinase levels on longitudinal changes in Alzheimer\u2019s disease (AD) biomarkers and cognitive function in patients with mild cognitive impairment due to AD registered in the Alzheimer\u2019s Disease Neuroimaging Initiative database.","volume":"416","author":"Abe","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jalz.2010.03.006","article-title":"Clinical core of the Alzheimer\u2019s disease neuroimaging initiative: Progress and plans.","volume":"6","author":"Aisen","year":"2010","journal-title":"Alzheimers Dement."},{"key":"B3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2023.05.012","article-title":"Matrix metalloproteinases are associated with brain atrophy in cognitively unimpaired individuals.","volume":"131","author":"Aksnes","year":"","journal-title":"Neurobiol. Aging"},{"key":"B4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13293-023-00514-x","article-title":"Sex-specific associations of matrix metalloproteinases in Alzheimer\u2019s disease.","volume":"14","author":"Aksnes","year":"","journal-title":"Biol. Sex Differ."},{"key":"B5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/(SICI)1097-4547(19980215)51:4lt;423::AID-JNR2<3.0.CO;2-E","article-title":"Central nervous system endothelium in neuroinflammatory, neuroinfectious, and neurodegenerative disease.","volume":"51","author":"Andjelkovic","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"105432","DOI":"10.1016\/j.neuint.2022.105432","article-title":"MMP-12 knockdown prevents secondary brain damage after ischemic stroke in mice.","volume":"161","author":"Arruri","year":"2022","journal-title":"Neurochem. Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e70269","DOI":"10.1111\/cns.70269","article-title":"Osteopontin in Alzheimer\u2019s disease: A double-edged sword in neurodegeneration and neuroprotection-a systematic review.","volume":"31","author":"Azizan","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3233\/JAD-170773","article-title":"The past and the future of Alzheimer\u2019s disease fluid biomarkers.","volume":"62","author":"Blennow","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease.","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3390\/biom12071006","article-title":"Immunohistochemical demonstration of the pGlu79 \u03b1-Synuclein fragment in Alzheimer\u2019s disease and its Tg2576 mouse model.","volume":"12","author":"Bluhm","year":"2022","journal-title":"Biomolecules"},{"key":"B11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/BF00294173","article-title":"Pathological alterations of the cerebral microvasculature in Alzheimer\u2019s disease and related dementing disorders.","volume":"87","author":"Bu\u00e9e","year":"1994","journal-title":"Acta Neuropathol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases.","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00223-002-1025-6","article-title":"The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility.","volume":"72","author":"Chellaiah","year":"2003","journal-title":"Calcif. Tissue Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e70089","DOI":"10.1002\/alz.70089","article-title":"Decreased water exchange rate across the blood-brain barrier throughout the Alzheimer\u2019s disease continuum: Evidence from Chinese data.","volume":"21","author":"Chen","year":"2025","journal-title":"Alzheimers Dement."},{"key":"B15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11883-009-0032-8","article-title":"Osteopontin: A multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification.","volume":"11","author":"Cho","year":"2009","journal-title":"Curr. Atheroscler. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3390\/cells12060962","article-title":"Biomarkers assessing endothelial dysfunction in Alzheimer\u2019s disease.","volume":"12","author":"Custodia","year":"2023","journal-title":"Cells"},{"key":"B17","doi-asserted-by":"publisher","first-page":"811210","DOI":"10.3389\/fnagi.2021.811210","article-title":"Endothelial progenitor cells and vascular alterations in Alzheimer\u2019s disease.","volume":"13","author":"Custodia","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/alz.12506","article-title":"Normal cerebrospinal fluid concentrations of PDGFR\u03b2 in patients with cerebral amyloid angiopathy and Alzheimer\u2019s disease.","volume":"18","author":"De Kort","year":"2022","journal-title":"Alzheimers Dement."},{"key":"B19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13195-019-0518-8","article-title":"Tau and atrophy: Domain-specific relationships with cognition.","volume":"11","author":"Digma","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3233\/JAD-200759","article-title":"Peripheral markers of vascular endothelial dysfunction show independent but additive relationships with brain-based biomarkers in association with functional impairment in Alzheimer\u2019s disease.","volume":"80","author":"Drake","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.exger.2009.09.005","article-title":"Blood-based biomarkers of microvascular pathology in Alzheimer\u2019s disease.","volume":"45","author":"Ewers","year":"2010","journal-title":"Exp. Gerontol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-031-89525-8_1","article-title":"Understanding the blood-brain barrier: From physiology to pathology.","volume":"1477","author":"Garcia-Gallardo","year":"2025","journal-title":"Adv. Exp. Med. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1742-2094-8-26","article-title":"Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer\u2019s disease.","volume":"8","author":"Grammas","year":"2011","journal-title":"J. Neuroinflamm."},{"key":"B24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/WAD.0000000000000623","article-title":"Evidence of pericyte damage in a cognitively normal cohort: Association with CSF and PET biomarkers of Alzheimer disease.","volume":"38","author":"Haghdel","year":"2024","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12987-025-00753-7","article-title":"Brain capillary endothelial-like cells show altered barrier functionality and reduced transport of amyloid \u03b2 in late-onset Alzheimer disease.","volume":"23","author":"Hartmann","year":"2026","journal-title":"Fluids Barriers CNS"},{"key":"B26","doi-asserted-by":"publisher","first-page":"102173","DOI":"10.1016\/j.arr.2023.102173","article-title":"Revision of Alzheimer\u2019s diagnostic criteria or relocation of the Potemkin village.","volume":"93","author":"H\u00f8ilund-Carlsen","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s43587-026-01081-7","article-title":"Identification of distinct and shared biomarker panels in different manifestations of cerebral small-vessel disease through proteomic profiling.","volume":"6","author":"Hristovska","year":"2026","journal-title":"Nat. Aging"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e14618","DOI":"10.1002\/alz.14618","article-title":"The interaction between dysfunction of vasculature and tauopathy in Alzheimer\u2019s disease and related dementias.","volume":"21","author":"Huang","year":"2025","journal-title":"Alzheimers Dement."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup.","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement."},{"key":"B30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: Toward a biological definition of Alzheimer\u2019s disease.","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5868","DOI":"10.3390\/ijms26125868","article-title":"Osteopontin: Its properties. recent studies, and potential applications.","volume":"26","author":"Karasalih","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s001250051007","article-title":"The incidence and characteristics of silent cerebral infarction in elderly diabetic patients: Association with serum-soluble adhesion molecules.","volume":"41","author":"Kawamura","year":"1998","journal-title":"Diabetologia"},{"key":"B33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: Where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3233\/JAD-150420","article-title":"Increased CSF E-Selectin in clinical Alzheimer\u2019s disease without altered CSF A\u03b242 and Tau.","volume":"47","author":"Li","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0123585","DOI":"10.1371\/journal.pone.0123585","article-title":"Periostin promotes neural stem cell proliferation and differentiation following hypoxic-ischemic injury.","volume":"10","author":"Ma","year":"2015","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus.","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"key":"B37","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction.","volume":"25","author":"Nation","year":"2019","journal-title":"Nat. Med."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-5404760\/v1","article-title":"Cerebrospinal Fluid (CSF) proteomic signature in preclinical and clinical Alzheimer\u2019s disease (AD): Role of adhesion molecules.","author":"Neal","year":"2025","journal-title":"Res. Sq. [Preprint]"},{"key":"B39","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma Phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders.","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1038\/s41467-026-70832-2","article-title":"Characterizing spatiotemporal white matter hyperintensity pathophysiology in vivo to disentangle vascular and neurodegenerative contributions.","volume":"17","author":"Parent","year":"2026","journal-title":"Nat. Commun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/jnr.21847","article-title":"Green tea polyphenol (-)-epigallocatechin gallate reduces neuronal cell damage and up-regulation of MMP-9 activity in hippocampal CA1 and CA2 areas following transient global cerebral ischemia.","volume":"87","author":"Park","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","article-title":"Microglial activation and tau propagate jointly across Braak stages.","volume":"27","author":"Pascoal","year":"2021","journal-title":"Nat. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neulet.2015.04.014","article-title":"Plasma gelsolin and matrix metalloproteinase 3 as potential biomarkers for Alzheimer disease.","volume":"595","author":"Peng","year":"2015","journal-title":"Neurosci. Lett."},{"key":"B44","doi-asserted-by":"publisher","first-page":"105150","DOI":"10.1016\/j.nbd.2020.105150","article-title":"A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer\u2019s pathology.","volume":"148","author":"Pentz","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e2218915120","DOI":"10.1073\/pnas.2218915120","article-title":"Definition of the contribution of an Osteopontin-producing CD11c+ microglial subset to Alzheimer\u2019s disease.","volume":"120","author":"Qiu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1161\/ATVBAHA.116.307610","article-title":"Endothelial cell junctional adhesion molecules: Role and regulation of expression in inflammation.","volume":"36","author":"Reglero-Real","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1080\/17425247.2025.2480654","article-title":"The blood-brain barrier as a treatment target for neurodegenerative disorders.","volume":"22","author":"Rust","year":"2025","journal-title":"Expert Opin. Drug Deliv."},{"key":"B48","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1124\/jpet.124.002280","article-title":"Molecular mechanisms underlying amyloid beta peptide mediated upregulation of vascular cell adhesion molecule-1 in Alzheimer disease.","volume":"391","author":"Salian","year":"2024","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e213438","DOI":"10.1212\/WNL.0000000000213438","article-title":"association of plasma biomarkers with longitudinal atrophy and microvascular burden on MRI across neurodegenerative and cerebrovascular diseases.","volume":"104","author":"Sanchez","year":"2025","journal-title":"Neurology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects.","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1093\/brain\/awac229","article-title":"Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer\u2019s disease.","volume":"145","author":"Tanner","year":"2022","journal-title":"Brain"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1093\/brain\/awt188","article-title":"Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer\u2019s Coordinating Centre.","volume":"136","author":"Toledo","year":"2013","journal-title":"Brain"},{"key":"B54","doi-asserted-by":"publisher","first-page":"106845","DOI":"10.1016\/j.nbd.2025.106845","article-title":"Towards a better diagnosis and treatment of dementia: Identifying common and distinct neuropathological mechanisms in Alzheimer\u2019s and vascular dementia.","volume":"208","author":"Vollhardt","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"105694","DOI":"10.1016\/j.ebiom.2025.105694","article-title":"Dissection of blood-brain barrier dysfunction through CSF PDGFR\u03b2 and amyloid, tau, neuroinflammation, and synaptic CSF biomarkers in neurodegenerative disorders.","volume":"115","author":"Vrillon","year":"2025","journal-title":"EBioMedicine"},{"key":"B56","doi-asserted-by":"publisher","first-page":"908636","DOI":"10.1155\/2014\/908636","article-title":"Matrix metalloproteinases and their multiple roles in Alzheimer\u2019s disease.","volume":"2014","author":"Wang","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"B57","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1750-1326-5-32","article-title":"Pericyte-specific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta receptor signaling.","volume":"5","author":"Winkler","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"B58","doi-asserted-by":"publisher","first-page":"26034","DOI":"10.31083\/FBL26034","article-title":"Mechanism of endothelial cell death in cerebral ischemic stroke and application of protective drugs.","volume":"30","author":"Yi","year":"2025","journal-title":"Front. Biosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/35081571","article-title":"Metalloproteinases in biology and pathology of the nervous system.","volume":"2","author":"Yong","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.3760\/cma.j.cn112137-20240505-01041","article-title":"Association between plasma osteopontin level and mild cognitive impairment in patients with type 2 diabetes mellitus.","volume":"104","author":"Yu","year":"2024","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B61","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","article-title":"Neurovascular mechanisms of Alzheimer\u2019s neurodegeneration.","volume":"28","author":"Zlokovic","year":"2005","journal-title":"Trends Neurosci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/j.1471-4159.2010.07002.x","article-title":"Low-density lipoprotein receptor-related protein-1: A serial clearance homeostatic mechanism controlling Alzheimer\u2019s amyloid \u03b2-peptide elimination from the brain.","volume":"115","author":"Zlokovic","year":"2010","journal-title":"J. Neurochem."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1744647\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:36:07Z","timestamp":1789968967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1744647\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":62,"alternative-id":["10.3389\/fnagi.2026.1744647"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1744647","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"article-number":"1744647"}}